Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 5

The DOI matches its Crossref record; the references it cites are not checked yet.

The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis

Sun, Jun, Dong, Yajun, Wang, Danhui, Yang, Yiting, Zhou, Zhou, Zhu, Min, Wang, Teng, Teng, Liping · 2024 · European Journal of Oncology Nursing

Abstract

PURPOSE Cancer-related cognitive impairment (CRCI) has garnered considerable attention, yet limited research has delved into nuanced distinctions among varying degrees of CRCI in colorectal cancer survivors. This study aimed to identify distinct subgroups based on the patterns of CRCI, assess the heterogeneity among different subgroups, and investigate the potential correlations between the subgroups of CRCI and inflammation-related biomarkers. METHODS 268 colorectal cancer patients were enrolled in this cross-sectional study, followed by the Functional Assessment of Cancer Therapy-Cognitive Function. The determination of CRCI subgroups was accomplished by the latent profile analysis (LPA). The effects of inflammation-related biomarkers on CRCI were examined using the binary logistic regression analysis. The receiver operating characteristic (ROC) curves assessed the diagnostic efficacy of inflammation-related biomarkers. RESULTS Two latent profiles were identified: CRCI (n = 64, 23.88%) and non-CRCI (n = 204, 76.12%). Independent factors for CRCI in colorectal cancer patients were SIRI (OR = 3.248, 95%CI [1.197-8.807], P = 0.021) and ALI (OR = 0.962, 95%CI [0.937-0.989], P = 0.005). The areas under the curve (AUCs) for SIRI and ALI in predicting CRCI were 0.781 and 0.774, with the optimal cut-off values being 0.70 and 37.04, respectively. CONCLUSIONS Colorectal cancer patients exhibited divergent cognitive performance profiles, categorized into two subgroups based on LPA. SIRI and ALI were identified as independent factors for CRCI, demonstrating strong diagnostic accuracy. These two inflammation-related biomarkers may potentially be novel indicators to identify and manage the development of CRCI among colorectal cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejon.2023.102493

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Cited by 5

Research works printed but not linked: 47

  1. Allegra, 2020, Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology, Expert Rev. Hematol., 13, 393, 10.1080/17474086.2020.1738213 · DOI
  2. Ashraf-Ganjouei, 2020, The association between systemic inflammation and cognitive performance in healthy adults, J. Neuroimmunol., 345, 10.1016/j.jneuroim.2020.577272 · DOI
  3. Bauer, 2022, Latent variable and clustering methods in intersectionality research: systematic review of methods applications, Soc. Psychiatr. Psychiatr. Epidemiol., 57, 221, 10.1007/s00127-021-02195-6 · DOI
  4. Bozdogan, 1987, Model selection and Akaike's Information Criterion (AIC): the general theory and its analytical extensions, Psychometrika, 52, 345, 10.1007/BF02294361 · DOI · Paper page
  5. Carragher, 2009, Subtypes of depression in a nationally representative sample, J. Affect. Disord., 113, 88, 10.1016/j.jad.2008.05.015 · DOI · Paper page
  6. Cerulla Torrente, 2020, Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy, J Cancer Surviv, 14, 464, 10.1007/s11764-020-00870-2 · DOI
  7. Chan, 2021, Systematic review of cognitive impairment in colorectal cancer survivors who received chemotherapy, Oncol. Nurs. Forum, 48, 634, 10.1188/21.ONF.634-647 · DOI
  8. Cheung, 2013, Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in asian patients with breast cancer, Value Health, 16, 1001, 10.1016/j.jval.2013.06.017 · DOI
  9. Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 · DOI · Paper page
  10. Dyk, 2019, vol. 4
  11. Fuca, 2021, The pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy, Targeted Oncol., 16, 529, 10.1007/s11523-021-00819-0 · DOI
  12. Gideon, 1978, Estimating the dimension of a model, Ann. Stat., 6, 461
  13. Guven, 2022, The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis, Cancers, 14, 2675, 10.3390/cancers14112675 · DOI · Paper page
  14. He, 2022, G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors, FEBS Open Bio, 12, 1268, 10.1002/2211-5463.13445 · DOI
  15. Howard, 2017, Variable-centered, person-centered, and person-specific approaches, Organ. Res. Methods, 21, 846, 10.1177/1094428117744021 · DOI · Paper page
  16. Jang, 2022, Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy, Neuron, 110, 3288, 10.1016/j.neuron.2022.08.009 · DOI
  17. Kusunoki, 2020, Advanced lung cancer inflammation index predicts outcomes of patients with colorectal cancer after surgical resection, Dis. Colon Rectum, 63, 1242, 10.1097/DCR.0000000000001658 · DOI
  18. Lange, 2019, Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors, Ann. Oncol., 30, 1925, 10.1093/annonc/mdz410 · DOI · Paper page
  19. Lee, 2019, Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer, Cancer Med., 8, 564, 10.1002/cam4.1956 · DOI
  20. Liu, 2022, Diagnostic value of carcinoembryonic antigen combined with multi-inflammatory cell ratios in colorectal cancer, Dis. Markers, 2022, 10.1155/2022/4889616 · DOI
  21. Llinas-Regla, 2017, The Trail making test, Assessment, 24, 183, 10.1177/1073191115602552 · DOI · Paper page
  22. Luo, 2022, Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies, Neurosci. Biobehav. Rev., 137, 10.1016/j.neubiorev.2022.104642 · DOI · Paper page
  23. Luo, 2023, The high burden of symptoms associated with cognitive impairment in lung cancer patients: a latent class analysis, Asia Pac J Oncol Nurs, 10, 10.1016/j.apjon.2023.100200 · DOI
  24. Mandelblatt, 2014, Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?, J. Clin. Oncol., 32, 1909, 10.1200/JCO.2013.54.2050 · DOI · Paper page
  25. Mayo, 2018, Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review, BMJ Open, 8, 10.1136/bmjopen-2017-017578 · doi:10.1136/bmjopen-2017-017578
  26. Mayo, 2021, Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group, Support. Care Cancer, 29, 2821
  27. Nguyen, 2020, Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases, EMBO Mol. Med., 12, 10.15252/emmm.202012075 · DOI · Paper page
  28. Nylund, 2007, Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study, Struct. Equ. Model., 14, 535, 10.1080/10705510701575396 · DOI · Paper page
  29. Oppegaard, 2022, Higher stress and symptom severity are associated with worse depressive symptom profiles in patients receiving chemotherapy, Eur. J. Oncol. Nurs., 58, 10.1016/j.ejon.2021.102031 · DOI
  30. Oppegaard, 2022, Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: a scoping review, Crit. Rev. Oncol. Hematol., 180, 10.1016/j.critrevonc.2022.103822 · DOI
  31. Orszaghova, 2021, Long-term cognitive dysfunction in cancer survivors, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.770413 · DOI · Paper page
  32. Pépin, 2021, Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment, Nephrol. Dial. Transplant., 37, ii23, 10.1093/ndt/gfab262 · DOI
  33. Piehl, 2022, Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment, Cell, 185, 5028, 10.1016/j.cell.2022.11.019 · DOI · Paper page
  34. Qi, 2016, A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy, Cancer, 122, 2158, 10.1002/cncr.30057 · DOI · Paper page
  35. Rick, 2022, Cancer-related cognitive dysfunction, Onkologe, 28, 231, 10.1007/s00761-021-01075-7 · DOI
  36. Root, 2022, Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: the Thinking and Living with Cancer Study, Breast Cancer Res. Treat., 194, 413, 10.1007/s10549-022-06623-2 · DOI
  37. Ryan, 2021, Normative performance of older individuals on the Hopkins Verbal Learning Test-Revised (HVLT-R) according to ethno-racial group, gender, age and education level, Clin. Neuropsychol., 35, 1174, 10.1080/13854046.2020.1730444 · DOI
  38. Santisteban, 2023, Hypertension, neurovascular dysfunction, and cognitive impairment, Hypertension, 80, 22, 10.1161/HYPERTENSIONAHA.122.18085 · DOI · Paper page
  39. Schietroma, 2022, Systemic inflammation response index (SIRI) as predictor of anastomotic leakage after total gastrectomy for gastric cancer, Surg Oncol, 43, 10.1016/j.suronc.2022.101791 · DOI
  40. Sclove, 1987, Application of model-selection criteria to some problems in multivariate analysis, Psychometrika, 52, 333, 10.1007/BF02294360 · DOI · Paper page
  41. Sharma, 2022, Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Gastroenterol Hepatol, 7, 627, 10.1016/S2468-1253(22)00044-9 · DOI · Paper page
  42. Shibutani, 2019, The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study, BMC Cancer, 19, 241, 10.1186/s12885-019-5468-9 · DOI
  43. Su, 2022, Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis, J. Affect. Disord., 308, 375, 10.1016/j.jad.2022.04.038 · DOI · Paper page
  44. Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA A Cancer J. Clin., 65, 123
  45. Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol., 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI · Paper page
  46. Yamamoto, 2021, Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients, Int. J. Mol. Sci., 22, 8002, 10.3390/ijms22158002 · DOI · Paper page
  47. Zhang, 2021, The activity of daily living (ADL) subgroups and health impairment among Chinese elderly: a latent profile analysis, BMC Geriatr., 21, 30, 10.1186/s12877-020-01986-x · DOI · Paper page

Metadata

Authors
Sun, J., Dong, Y., Wang, D., Yang, Y., Zhou, Z., Zhu, M., Wang, T., & Teng, L.
Venue
European Journal of Oncology Nursing
Publisher
Elsevier BV
Published
2024-02
Volume
68
Pages
102493
ISSN
1462-3889
Cited by
5
Language
en
Funders
National Natural Science Foundation of China (82172583)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis. https://app.cochat.ai/papers/10.1016/j.ejon.2023.102493
The paper
Sun, J., Dong, Y., Wang, D., Yang, Y., Zhou, Z., Zhu, M., Wang, T., & Teng, L. (2024). The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis. European Journal of Oncology Nursing. https://doi.org/10.1016/j.ejon.2023.102493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.